BioCentury
ARTICLE | Distillery Therapeutics

ISM1 as a therapy for diabetes, fatty liver disease

August 27, 2021 9:10 PM UTC

DISEASE CATEGORY: Endocrine/metabolic; hepatic

INDICATION: Diabetes; liver disease...

BCIQ Company Profiles

Stanford University

BCIQ Target Profiles

Isthmin 1 (ISM1)